Cargando…
Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease
Early detection of fibrosis progression is of major relevance for the diagnosis and management of patients with liver disease. This study was designed to find non-invasive biomarkers for fibrosis in a clinical context where this process occurs rapidly, HCV-positive patients who underwent liver trans...
Autores principales: | Marfà, Santiago, Crespo, Gonzalo, Reichenbach, Vedrana, Forns, Xavier, Casals, Gregori, Morales-Ruiz, Manuel, Navasa, Miquel, Jiménez, Wladimiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183580/ https://www.ncbi.nlm.nih.gov/pubmed/25275549 http://dx.doi.org/10.1371/journal.pone.0109254 |
Ejemplares similares
-
Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors
por: Kikuchi, Wataru, et al.
Publicado: (2016) -
Fibrinogen α-Chain as a Serum Marker of Liver Disease
por: Marfà, Santiago, et al.
Publicado: (2016) -
Is the 32-kDa fragment the functional enamelin unit in all species?
por: Brookes, Steven J, et al.
Publicado: (2011) -
Inmunosupresión en el trasplante hepático en la era covid-19
por: Forns, Xavier, et al.
Publicado: (2020) -
Liver transplant immunosuppression during the COVID-19 pandemic()
por: Forns, Xavier, et al.
Publicado: (2020)